Search Results - "ROBINS, R. A"
-
1
Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A
Published in Rheumatology (Oxford, England) (01-01-2006)“…Objective. To investigate the levels of the pro-inflammatory cytokines IL-6, TNF-α, IL-1β, IL-8, IL-10 and IL-12p70 in the plasma of patients with TNF…”
Get full text
Journal Article -
2
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients
Published in Cancer Immunology, Immunotherapy (01-10-2003)“…This study prospectively correlated the level of expression of CD55 on tumours with 7-year survival in 136 colorectal cancer patients. Patients with tumours…”
Get full text
Journal Article -
3
Monocytes Are Highly Sensitive to Clostridium difficile Toxin A-Induced Apoptotic and Nonapoptotic Cell Death
Published in Infection and Immunity (01-03-2005)“…In this study we investigated the in vitro responses of peripheral blood mononuclear preparations and purified monocytes to Clostridium difficile toxin A. In…”
Get full text
Journal Article -
4
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
Published in Acta Physiologica (01-05-2015)“…Aims To investigate the regulation of cannabinoid receptors CB1 and CB2 on immune cells by pro‐inflammatory cytokines and its potential relevance to the…”
Get full text
Journal Article -
5
Kinetics of immune cell migration at the human ocular surface
Published in British journal of ophthalmology (01-07-2008)“…The conjunctiva has a resident population of intraepithelial and stromal immune cells. These cells play an active part in ocular surface defence and disease…”
Get more information
Journal Article -
6
Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis
Published in Journal of leukocyte biology (01-05-2004)“…The novel, proinflammatory cytokine endothelial monocyte‐activating polypeptide‐II (EMAP‐II) was first found in tumor cell supernatants. EMAP‐II is closely…”
Get full text
Journal Article -
7
Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients
Published in Diabetic medicine (01-04-2005)“…Aims To determine the prevalence of autoantibodies in sera of Saudi diabetic patients including Type 1 and Type 2 diabetes mellitus (DM) and gestational…”
Get full text
Journal Article -
8
Decreased interferon‐β induced STAT‐4 activation in immune cells and clinical outcome in multiple sclerosis
Published in Acta neurologica Scandinavica (01-09-2017)“…Objectives Interferon‐β (IFN‐β) is used in the treatment of multiple sclerosis (MS). IFN‐β activation of signal transduction and activation of transcription…”
Get full text
Journal Article -
9
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
Published in British journal of cancer (01-06-2001)“…The cancer vaccine 105AD7 is an anti-idiotypic monoclonal antibody that mimics the tumour-associated antigen 791T/gp72 (CD55, Decay Accelerating Factor) on…”
Get full text
Journal Article -
10
Glucocorticoids increase CD4+CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis
Published in Acta neurologica Scandinavica (01-04-2009)“…Objectives – To determine whether percentages of CD4+CD25high T cells (a group of regulatory T cells, Treg) differ in patients with multiple sclerosis (MS) in…”
Get full text
Journal Article -
11
Th17/Th1 phenotype in demyelinating disease
Published in Cytokine (Philadelphia, Pa.) (01-04-2010)“…Background: Th17 cells are thought to contribute to the immunopathology of allergic and autoimmune conditions. Their role in multiple sclerosis (MS) pathology…”
Get full text
Journal Article -
12
Immunological aspects of head and neck cancer: Biology, pathophysiology and therapeutic mechanisms
Published in The surgeon (Edinburgh) (01-08-2004)“…Advanced cancer and head and neck cancer, in particular, remains a major clinical challenge with its associated morbidity and inevitable mortality. Local…”
Get full text
Journal Article -
13
Vaccination and malignant disease: Promising therapeutic approach
Published in The surgeon (Edinburgh) (01-06-2005)“…Immunotherapy of cancer is now entering its second century. Much of our understanding of the complex interaction between tumours and the host immune system has…”
Get full text
Journal Article -
14
A Neoadjuvant Clinical Trial in Colorectal Cancer Patients of the Human Anti-Idiotypic Antibody 105AD7, Which Mimics CD55
Published in Clinical cancer research (01-02-2000)“…Thirty-five patients received 105AD7 human anti-idiotype vaccination prior to surgery for colorectal carcinoma. Patients were immunized before and also…”
Get full text
Journal Article -
15
Preclinical evaluation of whole cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes
Published in Cancer research (Chicago, Ill.) (15-03-2000)“…The development of genetically modified "whole" tumor cell vaccines for cancer therapy relies on the efficient transduction and expression of genes by vectors…”
Get full text
Journal Article -
16
Vaccination therapy in malignant disease
Published in The surgeon (Edinburgh) (01-10-2006)“…Improvement in survival among patients with early malignancy is well established in various cancers. However, long-term survival in those with advanced…”
Get full text
Journal Article -
17
Loss of cytomegalovirus‐specific immunological memory in a patient with thymoma
Published in Clinical and experimental immunology (01-08-2002)“…SUMMARY Cytomegalovirus (CMV) retinitis is a re‐activation infection associated with severely impaired T cell‐mediated immunity. We describe a patient with…”
Get full text
Journal Article -
18
Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7
Published in Gut (01-10-1999)“…BACKGROUND The anti-idiotypic monoclonal antibody 105AD7 mimics the tumour associated antigen 791Tgp72, expressed on 70–80% of colorectal cancers. Phase I…”
Get full text
Journal Article -
19
S antigen specific effector T cell activation detected by cytokine flow cytometry
Published in British journal of ophthalmology (01-05-2002)“…Background/aims: Effector T cell activation is particularly important in the initiation of autoimmune uveitis. This pilot study seeks to demonstrate activation…”
Get full text
Journal Article -
20
105Ad7 cancer vaccine stimulates anti‐tumour helper and cytotoxic T‐cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses
Published in International journal of cancer (01-01-2000)“…105AD7 is a human anti‐idiotypic antibody that recognises the binding site of the anti‐tumour antibody 791T/36 and can thereby mimic the CD55 antigen. The…”
Get full text
Journal Article